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Background: Quantitative determination of the development of new blood vessels is crucial for our understanding
of the progression of several diseases, including cancer. However, in most cases a high throughput technique that
is simple, accurate, user-independent and cost-effective for small animal imaging is not available.
Methods: In this work we present a simple approach based on spectral imaging to increase the contrast between
vessels and surrounding tissue, enabling accurate determination of the blood vessel area. This approach is put to
test with a 4T1 breast cancer murine in vivo model and validated with histological and microvessel density analysis.
Results: We found that one can accurately measure the vascularization area by using excitation/emission filter
pairs which enhance the surrounding tissue’s autofluorescence, significantly increasing the contrast between
surrounding tissue and blood vessels. Additionally, we found excellent correlation between this technique and
histological and microvessel density analysis.
Conclusions: Making use of spectral imaging techniques we have shown that it is possible to accurately
determine blood vessel volume intra-vitally. We believe that due to the low cost, accuracy, user-independence and
simplicity of this technique, it will be of great value in those cases where in vivo quantitative information is
necessary.
Background
The development of new blood vessels or neoangiogen-
esis is a hallmark process in several biological stages but
also in the progression of numerous diseases, including
cancer [1]. It is known that in healthy adults angiogen-
esis occurs mainly during wound healing and the female
reproductive cycle [2], in which case its regulation is
strictly held by the balance of angiogenic activators and
inhibitors. However, during tumor development this bal-
ance is disrupted and inclined towards the pro-angio-
genic side: this ensures blood supply to the tumor cells
and contributes to the transport of malignant cells
through blood and/or lymph vessels for the develop-
ment of distant metastasis [3]. It is due to this change
in balance that the development of anti-angiogenic
treatments as a therapeutic target in oncology has raised
great interest [4]. Taking this into consideration,
experimental methods to estimate tissue vascularization
are crucial for the observation of blood vessels changes
i nt h ec o u r s eo fin vivo models, as well as the develop-
ment of potential treatments.
Currently, optical methods exist that can provide
i n f o r m a t i o no no x y g e ns a t u r a t i o na n db l o o dv o l u m e
in vivo in the intact animal [5] and functional optical
spectroscopy has also been successfully applied to
humans [6-9]. These techniques provide very impor-
tant information and can be directly applied in a clini-
cal environment and thus are extremely valuable.
However, they suffer from low spatial resolution (>1
mm in the best of cases) as might be needed in small
animal imaging studies. Other non-optical methodolo-
gies employ significantly more expensive techniques
such as positron emission tomography (PET), dynamic
contrast-enhanced magnetic resonance imaging (DCE-
MRI), perfusion computed tomography (CT), and
ultrasound (US) (see Ref. [10] for a review on the sub-
ject). However, the availability of these systems is lim-
ited and they are therefore not suitable for studies
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purpose, ex vivo, histological analysis of sections with
immunohistochemical staining of endothelial cell mar-
kers is probably the most recurrent method used.
Nevertheless, the appearance of blood vessels in these
sections is greatly influenced by their thickness and it
is restricted on a small part of the tissue, limiting the
accuracy of the method [10].
In order to obtain measurements as accurate as possi-
ble in vivo in a simple and efficient manner, we studied
the potential of intravital spectral imaging for vasculari-
zation measurements. Our results demonstrate that the
choice of the proper pair of exctitation/emission wave-
lengths allows an accurate discrimination between blood
vessels and the surrounding tissues. This, together with
a user-friendly software developed in-house, makes pos-
sible the quantitative determination of the area occupied
by blood vessels per squared millimeter of tissue. In this
work we put forward the experimental setup and
approaches used, finally presenting a validation of our
approach in a 4T1 breast cancer in vivo model by com-
paring with a more established technique such as micro-
vessel density of histological sections.
Methods
Animals
Balb/c mice were purchased from the Hellenic Pasteur
Institute (Athens, Greece) and were housed at the Uni-
versity of Crete School of Medicine, Greece. All proce-
dures described below were approved by the Animal
Care Committee of the University of Crete School of
Medicine, Heraklion, Greece, and by the Veterinary
Department of the Heraklion Prefecture, Heraklion,
Greece.
In vivo model of breast cancer cell
The mouse mammary tumor cell line 4T1 was cultured
and then used for the development of the in vivo model.
Cell culture took place in Dulbecco’s Modified Eagle
Medium (DMEM) medium supplemented with 10%
heat-inactivated fetal bovine serum (FBS) and 1% peni-
cillin/streptomycin (all purchased from GIBCO) at 37°C
in a 5% CO2 humidified atmosphere.
To develop the in vivo model, one million 4T1 cells
were implanted in the mammary fat pad of Balb/c
mice [11]. A control group was subjected to the same
surgical procedure, without the injection of tumor
cells. The tumors were let to grow for 6 weeks at
which point the mammary glands were visualized
intravitally to determine the extent of neoangiogenesis
following the procedure described above. Once fina-
lized the image acquisition process, samples were col-
lected from the different groups and histological
analysis was performed.
Histological analysis and microvessel density
measurement
Mammary pad samples were surgically removed and
fixed in formalin. Sections were stained with Haematox-
ylin-Eosin using standard techniques. For determination
of microvessel density (MVD) immunohistochemical
staining to detect CD31 expression was performed. Tis-
s u es e c t i o n sw e r ed e p a r a f f i nized, rehydrated and then
heated in a microwave oven at 600 W for 30 min in
Target Retrieval Buffer, pH = 6.0 (DakoCytomation).
After cooling for 20 min, standard immunohistochemis-
try procedures were performed using rabbit anti-mouse
CD31 (dilution 1:100, Acris Antibodies, Germany) and
the UltraVision Quanto Detection System HRP DAB kit
(Thermo Scientific, CA, USA), following the manufac-
turer’s recommendations.
In each case, 3-6 optical fields × 200 were selected.
Each positive endothelial cell cluster of immunoreactiv-
ity within the selected field was counted as an individual
vessel in addition to the morphologically identifiable
vessels with a lumen.
Statistical analysis
Comparison between groups was made using the Stu-
dent’s t-test and ANOVA test, and p < 0.05 was consid-
ered significant.
Results
Imaging Setup and Measurements
A Fluorescence Molecular Tomography (FMT) setup
developed at FORTH [12] has been adapted to perform
intravital measurements on small animals (see Figure 1).
The setup consists of several laser sources with wave-
lengths (488 nm, 590 nm, and 635 nm) that are guided
by mirrors and scanned in reflection mode on the whole
Figure 1 Experimental Setup.
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mice where anesthetized using vaporized 1.5% Isoflurane
(Tec-3, LUMIC International, Baltimore USA), and the
mammary fat pads were selected as the area of interest
(outlined in Figure 2). The laser is scanned while the
CCD camera is open, varying the exposure time and
laser speed to obtain optimal signal to noise ratios. For
each excitation wavelength several emission filters are
measured, building a library of emission-excitation
images. These images are then used to provide the opti-
mal source of contrast to distinguish blood vessels from
surrounding tissue. A software developed in-house was
designed to vary the contribution of each excitation/
emission image and apply a threshold, which was later
used to measure, with pixel-size accuracy, the vasculari-
zation area. Measurements on each animal took
approximately 10 minutes, after which all animals were
sacrificed.
Selection of the optimal contrast
In order to select the optimal excitation/emission pair,
we have studied different combinations of spectral
(emission-excitation) measurements in the visible range,
each one enhancing the contrast of blood and surround-
ing tissue differently (see Figure 2, were example images
are shown). A comparison of these contrasts is shown
in Figure 3, both making use of autofluorescence mea-
surements and excitation only measurements (’none’ in
Figures 2 and 3 stands for no emission filter used). The
reason for the changes in contrast can be understood by
comparing the excitation and emission wavelengths with
the blood absorption dependence with wavelength (Fig-
ure 4). As can be seen in this figure, it is the 488 nm
and lower wavelengths that will present a higher con-
trast due to the high absorption coefficient of blood at
these wavelengths. Due to the similar reasoning, the 635
nm excitation presents no contrast (in the order of 5%
as shown in Figure 3).
Software
Both the image acquisition and the image analysis soft-
ware have been developed under the Labview® environ-
ment. Within the image analysis window, by selecting
the appropriate excitation/emission pair (Ex = 488 nm/
Em = 550 nm) we are able to enhance the contrast
between blood and surrounding tissue. Figure 5 shows a
Figure 2 Contrast on mammary glands (dotted line) depending on the excitation and emission wavelengths pair selected. In this figure
‘none’ refers to not using an emission filter (i.e. only excitation light is collected).
Arranz et al. Journal of Angiogenesis Research 2010, 2:22
http://www.jangiogenesis.com/content/2/1/22
Page 3 of 6typical window from the in-house developed user-
friendly software, showing measurements equivalent to
those in Figure 2(a), (b) and 2(c). The high contrast
obtained with this excitation/emission pair allowed the
correct selection of the mask (see Figure 5). This mask
was then used to generate the blood vessel area data
shown in Figure 6. In order to obtain an accurate mask,
an edge detection algorithm was used.
Validation of the method on an in vivo breast cancer
model
In order to validate the applicability of this method, we
quantitatively measured the area of vascularization in an
in vivo breast cancer model [11]. For this purpose, 10
6
cells of the breast cancer cell line 4T1 were implanted
in the mammary fat pad of 13 Balb/c mice. Control
mice (N = 3) were subjected to the same surgical proce-
dure, but without the injection of tumor cells. Animals
were checked on a daily basis to ensure their welfare. 6
weeks after, we measured the area of vascularization in
both mammary fat pads of each mouse, following the
procedure described above. In order to validate the
results obtained with our method, tumor samples from
Figure 3 Contrast (%). Results for different Excitation and
Emissions. (***) indicates P < 0.001 Anova analysis.
Figure 4 Typical values for blood absorption curve (shown in
black). The Laser lines and filter widths are represented for
reference.
Figure 5 An example of the user friendly software for
measuring the vascularization area. Regions of Interest (ROI) A, B,
and C, correspond to three different excitation/emission pairs. The
final mask used to measure the number of pixels corresponding to
vessels or tissue can be seen at the top-left and top-middle,
respectively.
Figure 6 Vascularization Area Results. Quantification of the area
of vascularization as measured with the methodology described
herein, with P = 0.040 (Fig. 6a) and using Microvessel Density
analysis, with P = 0.037 (Fig. 7b). (*) indicates P < 0.05 T-student
analysis. Fig 6c shows the linear relationship between the
vascularization area results and microvessel density analysis (R
2 =
0.8256).
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and microvessel density (MVD) analyses performed.
Results from our method are shown in Figure 6a where,
as expected, tumor bearing mice show larger vasculari-
zation area. Results obtained using MVD are shown for
comparison in Figure 6b. Additionally, Figure 6c shows
the linear relationship between microvessel density and
the vascularization areas we obtained, reflecting the high
correlation between our in vivo method and histology.
Typical histological samples, both for the H&E and
CD31 staining are shown in Figure 7. These analyses
corroborate the enhanced angiogenesis in tumor bearing
samples.
Discussion
The great interest in the study of angiogenesis as an
essential process involved in tumorogenesis, as well as
in other physiological events like wound healing, makes
necessary the development of accurate methods capable
of measuring changes in vascularization.
Current in vivo optical methods such as functional
optical spectroscopy are not appropriate for small ani-
mal imaging studies due to their low spatial resolution.
On the other hand, more traditional in vivo imaging
modalities such as PET, MRI, CT and US require
expensive infrastructure, and typically have a limited
availability. In order to obtain higher resolution at the
cost of obtaining ex vivo information one could make
use of other traditional methods such as Immunohisto-
chemical staining. However, Immunohistochemical
staining is a time-consuming method, which requires
the fixation and process of the sample, not allowing
their use for other kind of analysis.
Herein we describe a simple, fast and cost-efficient
method to measure the vascularization area of exposed
tissue with pixel size resolution (in the order of 0.001
cm
2 in our case). Any technique capable of producing
images that clearly represent the blood vessels present
would be very useful in vascularization studies. In this
paper, we explore the approach of using the high tissue
autofluorescence and high blood absorption to obtain
such an image, in which case blood vessels appear very
dark surrounded by a bright (auto-fluorescent) back-
ground. We have shown that it is possible to accurately
determine the blood vessel area of exposed tissue by
using the appropriate combination of excitation/emis-
sion filter pairs, due to the enhanced contrast between
the blood vessels and the surrounding autofluorescent
tissue. Even though this technique has been applied
here to the specific case of mammary fat pads, it can be
used in any region where the blood vessels are accessi-
ble, such as the skin, the intestinal epithelium, solid
tumors and other tissues. Even though this technique
only probes superficial tissue, it has the advantage of
being user-independent and can allow scanning of the
entire tissue studied. This approach can also be
extended to the analysis of human surgically removed
specimen such as tumors, since it allows to accurately
analyze the entire sample without any processing. Addi-
tionally, considering the simplicity of our experimental
setup and the methodology described here, it should be
in principle possible to incorporate other optical techni-
ques such as laser Doppler flowmetry [13], or laser
speckle imaging [14] which would enable quantitative
measurement of spatio-temporal dynamics of blood
flow. One drawback of these techniques when used for
imaging large tissue sections is that they render grainy
images due to the difficult task of obtaining a significant
number of spatially different speckle patterns. The com-
bination of the methodology presented here with laser
Doppler flowmetry or speckle imaging would alleviate
this fact rendering, in principle, high resolution images
with dynamic information.
Conclusions
We have presented a study of the effect that different
combination of appropriate excitation/emission pairs
have on enhancing the contrast of hemoglobin against
surrounding tissue, finding that by selecting an excita-
tion wavelength in the 488 nm range and an emission in
the 550 nm range we obtain the maximum contrast.
This enhanced contrast has enabled the measurement of
vascularization area with pixel-size resolution. We have
presented an imaging setup and software which enables
such measurements, yielding a technique which is sim-
ple and fast, involving commercial laser sources. We
believe this approach will serve as an accurate tool in
biological studies where measurements of changes in
vascularization over large sample populations are
Figure 7 Histological analysis.R e p r e s e n t a t i v ei m a g e so ft h e
histological analysis are shown. Higher presence of vasculature is
appreciated in the tumor bearing sample compared with the
control.
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experimental setup it can be combined with other opti-
cal imaging approaches to offer quantitative information
of blood flow.
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